The portfolio includes thiocolchicoside, colchicine, nicotine, and vinpocetine, serving over 150 customers across 26 countries, with exports at 54% of segment revenue
Ennature Bio Pharma lists on NSE and BSE, targets branded nutraceuticals growth
The portfolio includes thiocolchicoside, colchicine, nicotine, and vinpocetine, serving over 150 customers across 26 countries, with exports at 54% of segment revenue
Key Takeaways
- Ennature Bio Pharma lists on NSE and BSE, targets branded nutraceuticals growth.
Read Complete Original Article
Published originally on The Hindu Business Line






